CSIMarket
 


Integrated Biopharma Inc  (INBP)
Other Ticker:  
 
 

INBP's Income from Cont. Operations Growth by Quarter and Year

Integrated Biopharma Inc's Income from Cont. Operations results by quarter and year




INBP Income from Cont. Operations (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
IV Quarter June - 0.04 1.49 4.51
III Quarter March - 0.02 0.80 1.24
II Quarter December -0.38 -0.06 1.03 1.22
I Quarter September -0.06 -0.04 0.52 1.04
FY   -0.44 -0.04 3.84 8.01



INBP Income from Cont. Operations second quarter 2024 Y/Y Growth Comment
Integrated Biopharma Inc in the second quarter 2024 recorded loss from continued operations of $ -0.38 millions.

Looking into second quarter 2024 results within Major Pharmaceutical Preparations industry 13 other companies have achieved higher Income from Cont. Operations growth. While Integrated Biopharma Inc' s Income from Cont. Operations no change of % ranks overall at the positon no. 671 in the second quarter 2024.




INBP Income from Cont. Operations ( Y/Y Growth %) 2024
2023 2022 2021
IV Quarter June - -97.32 % -66.96 % 137.37 %
III Quarter March - -97.5 % -35.48 % 31.91 %
II Quarter December - - -15.57 % 27.08 %
I Quarter September - - -50 % 235.48 %
FY   - - -52.06 % 94.89 %

Financial Statements
Integrated Biopharma Inc's second quarter 2024 Income from Cont. Operations $ -0.38 millions INBP's Income Statement
Integrated Biopharma Inc's second quarter 2023 Income from Cont. Operations $ -0.06 millions Quarterly INBP's Income Statement
New: More INBP's historic Income from Cont. Operations Growth >>


INBP Income from Cont. Operations (Quarter on Quarter Growth %)

2024
2023 2022 2021
IV Quarter June - 100 % 86.25 % 263.71 %
III Quarter March - - -22.33 % 1.64 %
II Quarter December - - 98.08 % 17.31 %
I Quarter September - - -88.47 % -45.26 %
FY (Year on Year)   - - -52.06 % 94.89 %




Income from Cont. Operations second quarter 2024 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #14
Healthcare Sector #50
Overall #671

Income from Cont. Operations Y/Y Growth Statistics
High Average Low
981.6 % 62.72 % -117.49 %
(Dec 31 2016)   (Dec 31 2023)
Income from Cont. Operations second quarter 2024 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #14
Healthcare Sector #50
Overall #671
Income from Cont. Operations Y/Y Growth Statistics
High Average Low
981.6 % 62.72 % -117.49 %
(Dec 31 2016)   (Dec 31 2023)

Income from Cont. Operations by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Integrated Biopharma Inc's Q/Q Income from Cont. Operations Growth


Income from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


INBP's II. Quarter Q/Q Income from Cont. Operations Comment
II. Quarter 2024 results of -0.38 millions by Integrated Biopharma Inc come out even worse if you take a look at -0.06 millions loss from continued operations in the first quarter.

Within Major Pharmaceutical Preparations industry Integrated Biopharma Inc achieved highest sequential Income from Cont. Operations growth. While Integrated Biopharma Inc's Income from Cont. Operations growth quarter on quarter, overall rank is .


Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


INBP's II. Quarter Q/Q Income from Cont. Operations Comment
Current accomplishment of -0.38 millions by Integrated Biopharma Inc appear even worse compare to the -0.06 millions loss from continued operations a quarter before.

Within Major Pharmaceutical Preparations industry Integrated Biopharma Inc achieved highest sequential Income from Cont. Operations growth. While Integrated Biopharma Inc's Income from Cont. Operations growth quarter on quarter, overall rank is .


Integrated Biopharma Inc's 12 Months Income from Cont. Operations Growth Year on Year


Income from Cont. Operations TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
Cumulative Income from Cont. Operations 12 Months Ending $ -0.39 $ -0.06 $ -0.03 $ 1.42 $ 2.20
Y / Y Income from Cont. Operations Growth (TTM) - - - -79.27 % -69.83 %
Year on Year Income from Cont. Operations Growth Overall Ranking # 812 # 1479 # 1806 # 597 # 371
Seqeuential Income from Cont. Operations Change (TTM) - - - -35.48 % -33.04 %
Seq. Income from Cont. Operations Growth (TTM) Overall Ranking # 1207 # 1274 # 1734 # 1107 # 943




Cumulative Income from Cont. Operations growth Comment
Integrated Biopharma Inc realized trailing twelve months loss from continued operations of $ 0 millions, in the Dec 31 2023, compare to Income from Cont. Operations of $ 2 millions a year ago.

In the Healthcare sector 58 other companies have achieved higher trailing twelve month Income from Cont. Operations growth. While Total ranking has impoved so far to 812, from total ranking in previous quarter at 1479.

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
981.6 %
62.72 %
-117.49 %
 

Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 21
Healthcare Sector # 59
Overall # 812

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
981.6 %
62.72 %
-117.49 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry # 21
Sector # 83
S&P 500 # 1207
Cumulative Income from Cont. Operations growth Comment
Integrated Biopharma Inc realized trailing twelve months loss from continued operations of $ 0 millions, in the Dec 31 2023, compare to Income from Cont. Operations of $ 2 millions a year ago.

In the Healthcare sector 58 other companies have achieved higher trailing twelve month Income from Cont. Operations growth. While Total ranking has impoved so far to 812, from total ranking in previous quarter at 1479.

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
981.6 %
62.72 %
-117.49 %
 


Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 21
Healthcare Sector # 59
Overall # 812

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
981.6 %
62.72 %
-117.49 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry # 21
Sector # 83
S&P 500 # 1207




Other Income from Cont. Operations Growth
Major Pharmaceutical Preparations Industry Income from Cont. Operations Growth Trends and Statistics
Healthcare Sector Income from Cont. Operations Growth Statistics
Income from Cont. Operations Growth Trends for overall market
INBP's Income from Cont. Operations Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Income from Cont. Operations Growth
Lowest Ranking Income from Cont. Operations Growth
Income from Cont. Operations Growth for INBP's Competitors
Income from Cont. Operations Growth for Integrated Biopharma Inc's Suppliers
Income from Cont. Operations Growth for INBP's Customers

You may also want to know
INBP's Annual Growth Rates INBP's Profitability Ratios INBP's Asset Turnover Ratio INBP's Dividend Growth
INBP's Roe INBP's Valuation Ratios INBP's Financial Strength Ratios INBP's Dividend Payout Ratio
INBP's Roa INBP's Inventory Turnover Ratio INBP's Growth Rates INBP's Dividend Comparisons



Companies with similar Income from Cont. Operations no change for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %Income from Cont. Operations for the quarter ending Dec 31 2023
Axonics Inc 888.57%$ 888.571 millions
Livanova Plc883.68%$ 883.685 millions
Incyte Corporation606.51%$ 606.507 millions
Docgo Inc 515.60%$ 515.603 millions
Insulet Corporation507.65%$ 507.647 millions
Kiniksa Pharmaceuticals ltd 465.73%$ 465.725 millions
Organon and Co 405.56%$ 405.556 millions
National Healthcare Corp401.70%$ 401.704 millions
Inspire Medical Systems inc 368.67%$ 368.667 millions
Nature s Sunshine Products inc 348.37%$ 348.369 millions
Progyny Inc 295.25%$ 295.246 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com